Results 291 to 300 of about 746,175 (357)

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo   +38 more
wiley   +1 more source

Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI. [PDF]

open access: yesBlood Adv
Goldenberg M   +9 more
europepmc   +1 more source

JP2 and JCN Crosstalk Abrogate MURF1-Mediated JCN Ubiquitination and Degradation in Cardiomyocytes. [PDF]

open access: yesJACC Basic Transl Sci
Ji X   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy